These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20121563)

  • 21. [Comparison of pragmatic clinical trials and explanatory clinical trials].
    Zhang YH; Liang WX; Zhu L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):161-4. PubMed ID: 19382481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analyses alongside randomised clinical trials.
    Gray AM
    Clin Trials; 2006; 3(6):538-42. PubMed ID: 17170038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple and valid tool distinguished efficacy from effectiveness studies.
    Gartlehner G; Hansen RA; Nissman D; Lohr KN; Carey TS
    J Clin Epidemiol; 2006 Oct; 59(10):1040-8. PubMed ID: 16980143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explanatory and pragmatic clinical trials: a primer and application to a recent asthma trial.
    Sackett DL
    Pol Arch Med Wewn; 2011; 121(7-8):259-63. PubMed ID: 21878863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in research of pragmatic-explanatory continuum indicator summary].
    Hu G; Hu Y; Zhan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In a clinical trial, method is not sufficient, the purpose must be relevant].
    Chêne G
    Rev Prat; 2000 Apr; 50(8):851-5. PubMed ID: 10874862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
    Elder WG; Munk N
    J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From the explanatory to the pragmatic].
    Flamant R
    Bull Cancer; 1987; 74(2):169-76. PubMed ID: 3607299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials.
    Bratton DJ; Nunn AJ
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):440-6. PubMed ID: 21396200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring functional outcome in paediatric patients with burns: methodological considerations.
    Simons M; Ziviani J; Tyack ZF
    Burns; 2004 Aug; 30(5):411-7. PubMed ID: 15225904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An economic approach to clinical trial design and research priority-setting.
    Claxton K; Posnett J
    Health Econ; 1996; 5(6):513-24. PubMed ID: 9003938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case.
    Maetzel A; Tugwell P; Boers M; Guillemin F; Coyle D; Drummond M; Wong JB; Gabriel SE;
    J Rheumatol; 2003 Apr; 30(4):891-6. PubMed ID: 12672224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pragmatic view on pragmatic trials.
    Patsopoulos NA
    Dialogues Clin Neurosci; 2011; 13(2):217-24. PubMed ID: 21842619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.
    Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L
    Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.